Publications in OpenAlex of which a co-author is affiliated to this organization
All publications | By field | By subfield
All publications [Next]
| Title | DOI |
|---|---|
| https://doi.org/10.1016/j.jad.2010.09.001 | Self-stigma, empowerment and perceived discrimination among people with bipolar disorder or depression in 13 European countries: The GAMIAN–Europe study |
| https://doi.org/10.1093/schbul/sbu006 | Schizophrenia--Time to Commit to Policy Change |
| https://doi.org/10.1002/wps.20959 | The lived experience of psychosis: a bottom‐up review co‐written by experts by experience and academics |
| https://doi.org/10.1038/s41380-021-01381-x | A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials |
| https://doi.org/10.1016/j.euroneuro.2022.08.001 | Ethical considerations for precision psychiatry: A roadmap for research and clinical practice |
| https://doi.org/10.1186/s13063-020-04686-4 | Tailored implementation of internet-based cognitive behavioural therapy in the multinational context of the ImpleMentAll project: a study protocol for a stepped wedge cluster randomized trial |
| https://doi.org/10.1159/000528513 | The Lived Experiences of Family Members and Carers of People with Psychosis: A Bottom-Up Review Co-Written by Experts by Experience and Academics |
| https://doi.org/10.2196/41532 | Effectiveness of Self-guided Tailored Implementation Strategies in Integrating and Embedding Internet-Based Cognitive Behavioral Therapy in Routine Mental Health Care: Results of a Multicenter Stepped-Wedge Cluster Randomized Trial |
| https://doi.org/10.1016/j.biopsych.2024.01.001 | How Real-World Data Can Facilitate the Development of Precision Medicine Treatment in Psychiatry |
| https://doi.org/10.1016/s2215-0366(23)00345-0 | Psychopharmacology in children and adolescents: unmet needs and opportunities |
| https://doi.org/10.1007/s00406-016-0677-6 | European Psychiatric Association (EPA) guidance on the quality of eMental health interventions in the treatment of psychotic disorders |
| https://doi.org/10.1016/j.eurpsy.2018.06.007 | Value of schizophrenia treatment I: The patient journey |
| https://doi.org/10.1192/j.eurpsy.2023.2432 | The future of diagnosis in clinical neurosciences: Comparing multiple sclerosis and schizophrenia |
| https://doi.org/10.1080/2575517x.2019.1617575 | Manifesto for an international digital mental health network |
| https://doi.org/10.1192/j.eurpsy.2022.2307 | Joint European policy on the COVID-19 risks for people with mental disorders: An umbrella review and evidence- and consensus-based recommendations for mental and public health |
| https://doi.org/10.3390/ph17020151 | A New Intervention for Implementation of Pharmacogenetics in Psychiatry: A Description of the PSY-PGx Clinical Study |
| https://doi.org/10.1002/wps.21289 | |
| https://doi.org/10.1016/j.biopsych.2023.11.015 | Empowering Experts by Experience to Guide Ethical Precision Psychiatry |
| https://doi.org/10.1192/j.eurpsy.2024.1806 | Use of psychedelic treatments in psychiatric clinical practice: an EPA policy paper |
| https://doi.org/10.1016/j.eurpsy.2015.01.011 | European Psychiatric Association (EPA) guidance on quality assurance in mental healthcare |
| https://doi.org/10.1002/wps.21074 | Violence and schizophrenia: the role of social determinants of health and the need for early intervention |
| https://doi.org/10.1111/ejn.13236 | Consensus Statement on European Brain Research: the need to expand brain research in Europe – 2015 |
| https://doi.org/10.15256/joc.2016.6.75 | Managing Multimorbidity: How Can the Patient Experience be Improved? |
| https://doi.org/10.1016/j.eurpsy.2018.06.008 | Value of schizophrenia treatment II: Decision modelling for developing early detection and early intervention services in the Czech Republic |
| https://doi.org/10.3390/psychiatryint2020010 | What Is the Capacity of Individuals with Schizophrenia and Bipolar Disorder to Make Healthcare Decisions? An Exploratory Study of the Views of Patients, Psychiatrists, and Family Caregivers—A Survey on Decisional Capacity in Mental Health |
| https://doi.org/10.1007/978-3-319-27839-1_10 | The Viewpoint of GAMIAN*-Europe |
| https://doi.org/10.1192/j.eurpsy.2024.1585 | Rethinking Schizophrenia: Beyond the Voices of Schizophrenia |
| Normobaric oxygen can enhance protein captation by the lymphatic system in healthy humans. | |
| https://doi.org/10.2139/ssrn.4703933 | Schizophrenia - Time to Commit to Policy Change |
| https://doi.org/10.1007/978-3-642-58729-0_12 | Modelling Studies |
| https://doi.org/10.7748/mhp.8.7.24.s20 | My mental health |
| https://doi.org/10.1007/978-981-10-0866-5_19-1 | What Do Patients Expect from a Psychiatrist? |
| https://doi.org/10.1192/j.eurpsy.2021.97 | Service user perspectives on coercion in mental health |
| https://doi.org/10.1007/978-981-10-2350-7_19 | What Do Patients Expect from a Psychiatrist? |
| https://doi.org/10.1016/j.nsa.2024.105110 | Involvement of persons with lived experience in mental health research: a roadmap |
| https://doi.org/10.1192/j.eurpsy.2025.502 | Rethinking Pathways: Innovative Approaches to Identify Individuals Experiencing First-Episode Psychosis and Connect Them to Care |
| https://doi.org/10.1192/j.eurpsy.2025.10123 | Improvements in health-related quality of life with esketamine nasal spray versus quetiapine extended release |
| https://doi.org/10.1101/2025.11.14.25339774 | TRUSTING: An International Multicenter Observational Study of Speech-Based Relapse Prediction in Psychosis Using Explainable AI |
| https://doi.org/10.1192/j.eurpsy.2026.10172 | Rethinking Schizophrenia: Optimizing Care Pathways in Europe from the First Episode of Psychosis to Long-Term Care |